Nectar Lifesciences Ltd. - Research Center
532649 NECLIFE Group (B) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
792.09 |
791.67 |
919.23 |
749.02 |
816.16 |
Operating profit |
62.41 |
34.44 |
95.74 |
63.10 |
48.21 |
Interest |
38.14 |
42.35 |
35.06 |
43.75 |
55.75 |
Gross profit |
35.34 |
3.16 |
61.73 |
29.59 |
-6.49 |
EPS (Rs) |
0.13 |
-0.83 |
0.95 |
0.18 |
-1.08 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
11.08 |
11.07 |
1.05 |
10.24 |
1.05 |
Stock adjustment |
27.14 |
-22.51 |
16.07 |
-1.10 |
45.95 |
Raw material |
539.81 |
620.77 |
658.10 |
548.78 |
576.55 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
39.11 |
37.75 |
38.94 |
35.61 |
36.03 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
123.62 |
121.21 |
110.38 |
102.64 |
109.42 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
30.64 |
29.49 |
28.54 |
28.43 |
30.14 |
Taxation |
1.86 |
-7.79 |
11.81 |
-2.78 |
-12.50 |
Net profit / loss |
2.84 |
-18.53 |
21.39 |
3.93 |
-24.13 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
22.43 |
22.43 |
22.43 |
22.43 |
22.43 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
7.88 |
4.35 |
10.42 |
8.42 |
5.91 |
GPM (%) |
4.40 |
.39 |
6.71 |
3.90 |
-.79 |
NPM (%) |
0.35 |
-2.31 |
2.32 |
0.52 |
-2.95 |